The Peptide Oxytocin Antagonist F-792, When Given Systemically, Does Not Act Centrally in Lactating Rats.

Area of Science:

• Neuroendocrinology
• Pharmacology
• Reproductive Biology

Background:

• Oxytocin plays crucial roles in childbirth and lactation by stimulating uterine contractions and milk ejection.
• Oxytocin also acts centrally, regulating its own release through auto-excitation of oxytocin neurons.
• Systemic oxytocin antagonists like atosiban are used clinically, raising questions about their central nervous system penetration.

Purpose of the Study:

• To determine if the peptide oxytocin antagonist F792, when administered systemically, can cross the blood-brain barrier.
• To assess the impact of systemic F792 on both peripheral and central oxytocin-mediated functions.
• To evaluate the potential of systemic peptide antagonists for exploring central oxytocin functions.

Main Methods:

• Experiments were conducted on urethane-anesthetized, suckled rats.
• The effects of intravenous (i.v.) and intracerebral F792 injections on mammary gland responsiveness and milk-ejection reflex were assessed.
• Oxytocin neuron activity in the paraventricular nucleus was recorded to evaluate central effects of systemically administered F792.

Main Results:

• Intravenous F792 (7 µg/kg) blocked peripheral oxytocin's action on mammary glands.
• Direct brain administration of F792 (0.2 µg) blocked the milk-ejection reflex.
• Systemic F792 (100 µg/kg i.v.) did not affect oxytocin neuron burst-firing during suckling, indicating it did not enter the brain.

Conclusions:

• The peptide oxytocin antagonist F792 does not penetrate the brain from the systemic circulation.
• Systemic administration of F792 effectively blocks peripheral oxytocin actions but not central oxytocin-mediated neuronal activity.
• Exploring central oxytocin functions using systemic peptide antagonists is not feasible due to their inability to cross the blood-brain barrier.